Evaluation of IL-35, as a Possible Biomarker for Follow-Up after Therapy, in Chronic Human Schistosoma Infection.
Vaccines (Basel)
; 11(5)2023 May 17.
Article
in En
| MEDLINE
| ID: mdl-37243099
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Vaccines (Basel)
Year:
2023
Document type:
Article
Affiliation country:
Italy
Country of publication:
Switzerland